Table 3 Clinical data and biochemical assessments of subjects with T1D.
T1D (n = 23) | |
|---|---|
Age at diabetes onset (years) | 5.7 (2.8) |
5.0 (1.0; 11.0) | |
Diabetes duration (years) | 18.9 (2.2) |
18.5 (15.8; 23.0) | |
Insulin MDI | 12 (52.2%) |
Insulin pump | 11 (47.8%) |
Last HbA1c measurement (mmol/mol) | 68.1 (13.0) |
63.0 (49.0; 94.0) | |
HbA1c since 18 years of age (mmol/mol) | 72.1 (15.8) |
69.2 (49.1; 108.5) | |
HbA1c, 0–8.9 years (mmol/mol) | 59.3 (12.3) |
58.8 (25.5; 106.9) | |
HbA1c, 9.0–13.9 year (mmol/mol) | 64.3 (11.9) |
64.0 (31.3; 94.0) | |
HbA1c, 14.0–18.0 years (mmol/mol) | 69.7 (13.8) |
69.2 (35.3; 107.0) | |
Microalbuminuria | 0 (0.0%) |
eGFR (MDRD) | 111.1 (23.9) |
108.4 (71.7; 178.3) n = 22 | |
Retinopathy | 15 (65.2%) |
Retinopathy stages | |
None | 8 (34.8%) |
Simplex | 8 (34.8%) |
Maculopathy | 5 (21.7%) |
Proliferative diabetes retinopathy | 2 (8.7%) |
Total cholesterol (mmol/L) | 4.45 (0.64) |
4.45 (3.30; 5.70) n = 22 | |
Low-density lipoprotein (mmol/L) | 2.36 (0.52) |
2.36 (1.49; 3.85) n = 22 | |
Systolic blood pressure (mmHg) | 112.5 (10.0) |
110.0 (95.0; 136.0) | |
Diastolic blood pressure (mmHg) | 68.0 (10.0) |
70.0 (40.0; 82.0) | |
High blood pressure (≥ 130/80 mmHg) | 5 (21.7%) |
